KPMG's latest report on China's life science sector notes that the country is set to become a crucial player in the life science and healthcare industry. Within a decade it is expected to become a global leader in drug discovery and innovation.
This report makes a compelling read for any organisation that is either planning or implementing a cloud strategy, and provides some practical and actionable advice for enterprises and their executives.
Please contact us if you have any questions about our services or on any other matter. You are also welcome to contact Partners and staff of the Valuation & Modelling service team.
Janet Cheung
Head of Valuation Services, China and HK SAR
+852 2140 2818
Robert Kwok
Partner, Beijing
+86 (10) 8508 5810
Linda Chen
Partner, Shanghai
+86 (21) 2212 3660
Subscribe to receive email alerts or e-Newsletters from KPMG China when new updates are available.